Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Publications

WO 2018/220390

VATISH M. et al, (2020)

WO 2019/197838

VATISH M., (2020)

Abnormal uterine inflammation in obstetric syndromes: molecular insights into the role of chemokine decoy receptor D6 and inflammasome NLRP3.

Tersigni C. et al, (2020), Molecular human reproduction, 26, 111 - 121

Exosomal Th1/Th2 cytokines in preeclampsia and HIV-positive preeclamptic women on highly active anti-retroviral therapy.

Pillay P. et al, (2020), Cytokine, 125

Transcriptomic profiling of trophoblast fusion using BeWo and JEG-3 cell lines.

Msheik H. et al, (2019), Molecular human reproduction, 25, 811 - 824

Predictive Performance of PlGF (Placental Growth Factor) for Screening Preeclampsia in Asymptomatic Women

Agrawal S. et al, (2019), Hypertension, 74, 1124 - 1135

Maternal circulating syncytiotrophoblast-derived extracellular vesicles contain biologically active 5'-tRNA halves.

Cooke WR. et al, (2019), Biochem Biophys Res Commun, 518, 107 - 113

A top priority in pre-eclampsia research: development of a reliable and inexpensive urinary screening test.

Scioscia M. et al, (2019), Lancet Glob Health, 7, e1312 - e1313

Identification of infants with increased type 1 diabetes genetic risk for enrollment into Primary Prevention Trials-GPPAD-02 study design and first results.

Winkler C. et al, (2019), Pediatr Diabetes, 20, 720 - 727

IFPA meeting 2018 workshop report II: Abnormally invasive placenta; inflammation and infection; preeclampsia; gestational trophoblastic disease and drug delivery

Albrecht C. et al, (2019), Placenta, 84, 9 - 13

Randomized Interventional Study on Prediction of Preeclampsia/Eclampsia in Women With Suspected Preeclampsia.

Cerdeira AS. et al, (2019), Hypertension (Dallas, Tex. : 1979), HYPERTENSIONAHA11912739 - HYPERTENSIONAHA11912739

SYNCYTIOTROPHOBLAST EXTRACELLULAR VESICLES FROM LATE-ONSET PREECLAMPSIA PLACENTAE DO NOT INDUCE A PRO-INFLAMMATORY IMMUNE RESPONSE IN THP-1 MACROPHAGES

Motta-Mejia C. et al, (2019), PLACENTA, 83, E105 - E105

SYNCYTIOTROPHOBLAST EXTRACELLULAR VESICLES EXPRESS FUNCTIONAL INSULIN RECEPTOR CAPABLE OF BINDING INSULIN; CIRCULATING LEVELS ARE INCREASED IN GESTATIONAL DIABETES MELLITUS

Kandzija N. et al, (2019), PLACENTA, 83, E95 - E96

Diagnostic utility of angiogenic biomarkers in pregnant women with suspected preeclampsia: A health economics review

Schlembach D. et al, (2019), Pregnancy Hypertension, 17, 28 - 35

The role of angiogenic factors in the management of preeclampsia.

Flint EJ. et al, (2019), Acta Obstet Gynecol Scand, 98, 700 - 707

The role of procalcitonin in the diagnosis of histologically confirmed chorioamnionitis: a systematic review

Dockree S. et al, (2019), BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 126, 160 - 161

Placental Syncytiotrophoblast-Derived Extracellular Vesicles Carry Active NEP (Neprilysin) and Are Increased in Preeclampsia.

Gill M. et al, (2019), Hypertension (Dallas, Tex. : 1979), 73, 1112 - 1119

Circulating soluble fms-like tyrosine kinase-1 is placentally derived in normal pregnancy: First in vivo evidence.

Cerdeira AS. et al, (2019), Pregnancy Hypertens, 16, 145 - 147

Soluble fms-like tyrosine kinase-1 to placental growth factor ratio: ruling out pre-eclampsia for up to 4 weeks and value of retesting

Zeisler H. et al, (2019), Ultrasound in Obstetrics & Gynecology, 53, 367 - 375

Deep clinical and biological phenotyping of the preterm birth and small for gestational age syndromes: The INTERBIO-21st Newborn Case-Control Study protocol

Kennedy SH. et al, (2019), Gates Open Research, 2, 49 - 49

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?